Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Disposition to Issuer of 85,153 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 85,153 | n/a |
| Jun 24, 2026 | FibroBiologics, Inc. (FBLG) | Grant/Award | 30,803 | n/a |
| Jun 1, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 79,873 | n/a |
| Mar 24, 2026 | CytoDyn Inc. (CYDY) | Grant/Award | 4,874,691 | n/a |
| Feb 17, 2026 | TuHURA Biosciences, Inc./NV (HURA) | Grant/Award | 156,240 | n/a |
| Jun 12, 2025 | FibroBiologics, Inc. (FBLG) | Grant/Award | 22,000 | n/a |
| Jun 2, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 5,280 | n/a |
| May 23, 2025 | CytoDyn Inc. (CYDY) | Grant/Award | 1,000,000 | n/a |
| Apr 2, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 40,000 | n/a |
| Jan 6, 2025 | TuHURA Biosciences, Inc./NV (HURA) | Grant/Award | 51,275 | n/a |